Expert Speaker Faculty

Take a look at the globally recognised speaker faculty for the 16th Clinical Biomarkers & Companion Diagnostics Summit Europe.

Category 1
Category 2
Category 3
Category 4

Category 1

Charlotte Herd

Associate Director, International Marketing, Precision Medicine, Oncology
Abbvie

David Krige

Chief Development Officer
Accession Therapeutics

Monika Lamba

Global Translational Pathology Leader
ADC Therapeutics

Stewart McWilliams

Global Vice President, Quality & Regulatory Affairs
Almac Diagnostic Services

EK Kim

Head of Global Commercial Biomarkers & Diagnostics
Amgen

Aino Telaranta-Keerie

Senior Director, Global Precision Medicine Lead
Astellas Pharma

Sophie Wildsmith

Executive Director, Head of PMB Immuno-Oncology (IO) Franchise
AstraZeneca

Ruairidh Edwards

Translational Scientist
Avacta Therapeutics

Anna Ettorre

Director Translational Science, Bioassays & Biomarkers
AviadoBio

Kate Simon

Senior Director, Global Regulatory Strategy IVD
Bayer

Kathrin Schlüter

Medical Affairs Manager (Europe, Middle East, & Africa)
BD Medical Essentials, Specimen Management

Dennis Merkle

CDx Commercialization Lead
Boehringer Ingelheim

Simon Vincent

Chief Scientific Officer
Breast Cancer Now

Jonathan Beer

Senior Director, Precision Medicine
Bristol Myers Squibb

Angela Douglas

President
British In Vitro Diagnostics Association

Dominic Smeithurst

Chief Medical Officer
Corbus Pharmaceuticals

Nicole Chaves Petronzi

Senior Director, Global Regulatory Affairs Diagnostics
Eli Lilly & Co.

Matthew Brown

Chief Scientific Officer
Genomics England

Eleanor Barr

AI Product Manager
GlaxoSmithKline

Catherine Mela

Executive Director, Head Biomarker Operations
GlaxoSmithKline

Sarah Stanhope

Director Translational Medicine
Immunocore

Leonie De Visser

EMEA Disease Team Leader, Bladder Cancer
Johnson & Johnson, Innovative Medicine

Dany Bell

Strategic Adviser Cancer Care
Macmillan Cancer Support

Lorna McInroy

Director, Clinical Biomarkers
Moderna

Kiri Granger

Co-Founder & Chief Scientific Officer
Monument Therapeutics

Radha Krishnan

Executive Director, Head of Clinical Pathology
MSD

Hilke Zander

Clinical Assessor
Paul-Ehrlich-Institut, National Competent Authority for Medicinal Products & CDx Devices

Jörg Engelbergs

Scientific-Regulatory Assessor Targeted & Personalized Biomedicines
Paul-Ehrlich-Institut, National Competent Authority for Medicinal Products & CDx Devices

Jason Simon

Precision Medicine Professionals
Regeneron

Jai Pandey

Head, Global Device Regulatory for IVDs & Digital Health
Sanofi

Philip Beer

Chief Scientific Officer
Step Pharma

Franz Stark

Senior Manager, Quality Assurance IVDs
Takeda

Alastair Greystoke

Honorary Medical Oncologist & Professor of Oncology
The Newcastle upon Tyne Hospitals NHS Foundation Trust & Newcastle University

Rolf Thermann

Section Manager IVD & Companion Diagnostics Lead
TUV Rheinland

Paola Nasuti

Real-World Evidence Senior Strategy Lead
UCB

Neil Hawkins

Professor, Health Technology Assessment
University of Glasgow

Jose Munoz-Olaya

Chief Scientific Officer
Valink Therapeutics

Category 2

Charlotte Herd

Associate Director, International Marketing, Precision Medicine, Oncology
Abbvie

David Krige

Chief Development Officer
Accession Therapeutics

Monika Lamba

Global Translational Pathology Leader
ADC Therapeutics

Stewart McWilliams

Global Vice President, Quality & Regulatory Affairs
Almac Diagnostic Services

EK Kim

Head of Global Commercial Biomarkers & Diagnostics
Amgen

Aino Telaranta-Keerie

Senior Director, Global Precision Medicine Lead
Astellas Pharma

Sophie Wildsmith

Executive Director, Head of PMB Immuno-Oncology (IO) Franchise
AstraZeneca

Ruairidh Edwards

Translational Scientist
Avacta Therapeutics

Anna Ettorre

Director Translational Science, Bioassays & Biomarkers
AviadoBio

Kate Simon

Senior Director, Global Regulatory Strategy IVD
Bayer

Kathrin Schlüter

Medical Affairs Manager (Europe, Middle East, & Africa)
BD Medical Essentials, Specimen Management

Dennis Merkle

CDx Commercialization Lead
Boehringer Ingelheim

Simon Vincent

Chief Scientific Officer
Breast Cancer Now

Jonathan Beer

Senior Director, Precision Medicine
Bristol Myers Squibb

Angela Douglas

President
British In Vitro Diagnostics Association

Dominic Smeithurst

Chief Medical Officer
Corbus Pharmaceuticals

Nicole Chaves Petronzi

Senior Director, Global Regulatory Affairs Diagnostics
Eli Lilly & Co.

Matthew Brown

Chief Scientific Officer
Genomics England

Eleanor Barr

AI Product Manager
GlaxoSmithKline

Catherine Mela

Executive Director, Head Biomarker Operations
GlaxoSmithKline

Sarah Stanhope

Director Translational Medicine
Immunocore

Leonie De Visser

EMEA Disease Team Leader, Bladder Cancer
Johnson & Johnson, Innovative Medicine

Dany Bell

Strategic Adviser Cancer Care
Macmillan Cancer Support

Lorna McInroy

Director, Clinical Biomarkers
Moderna

Kiri Granger

Co-Founder & Chief Scientific Officer
Monument Therapeutics

Radha Krishnan

Executive Director, Head of Clinical Pathology
MSD

Hilke Zander

Clinical Assessor
Paul-Ehrlich-Institut, National Competent Authority for Medicinal Products & CDx Devices

Jörg Engelbergs

Scientific-Regulatory Assessor Targeted & Personalized Biomedicines
Paul-Ehrlich-Institut, National Competent Authority for Medicinal Products & CDx Devices

Jason Simon

Precision Medicine Professionals
Regeneron

Jai Pandey

Head, Global Device Regulatory for IVDs & Digital Health
Sanofi

Philip Beer

Chief Scientific Officer
Step Pharma

Franz Stark

Senior Manager, Quality Assurance IVDs
Takeda

Alastair Greystoke

Honorary Medical Oncologist & Professor of Oncology
The Newcastle upon Tyne Hospitals NHS Foundation Trust & Newcastle University

Rolf Thermann

Section Manager IVD & Companion Diagnostics Lead
TUV Rheinland

Paola Nasuti

Real-World Evidence Senior Strategy Lead
UCB

Neil Hawkins

Professor, Health Technology Assessment
University of Glasgow

Jose Munoz-Olaya

Chief Scientific Officer
Valink Therapeutics

Category 3

Charlotte Herd

Associate Director, International Marketing, Precision Medicine, Oncology
Abbvie

David Krige

Chief Development Officer
Accession Therapeutics

Monika Lamba

Global Translational Pathology Leader
ADC Therapeutics

Stewart McWilliams

Global Vice President, Quality & Regulatory Affairs
Almac Diagnostic Services

EK Kim

Head of Global Commercial Biomarkers & Diagnostics
Amgen

Aino Telaranta-Keerie

Senior Director, Global Precision Medicine Lead
Astellas Pharma

Sophie Wildsmith

Executive Director, Head of PMB Immuno-Oncology (IO) Franchise
AstraZeneca

Ruairidh Edwards

Translational Scientist
Avacta Therapeutics

Anna Ettorre

Director Translational Science, Bioassays & Biomarkers
AviadoBio

Kate Simon

Senior Director, Global Regulatory Strategy IVD
Bayer

Kathrin Schlüter

Medical Affairs Manager (Europe, Middle East, & Africa)
BD Medical Essentials, Specimen Management

Dennis Merkle

CDx Commercialization Lead
Boehringer Ingelheim

Simon Vincent

Chief Scientific Officer
Breast Cancer Now

Jonathan Beer

Senior Director, Precision Medicine
Bristol Myers Squibb

Angela Douglas

President
British In Vitro Diagnostics Association

Dominic Smeithurst

Chief Medical Officer
Corbus Pharmaceuticals

Nicole Chaves Petronzi

Senior Director, Global Regulatory Affairs Diagnostics
Eli Lilly & Co.

Matthew Brown

Chief Scientific Officer
Genomics England

Eleanor Barr

AI Product Manager
GlaxoSmithKline

Catherine Mela

Executive Director, Head Biomarker Operations
GlaxoSmithKline

Sarah Stanhope

Director Translational Medicine
Immunocore

Leonie De Visser

EMEA Disease Team Leader, Bladder Cancer
Johnson & Johnson, Innovative Medicine

Dany Bell

Strategic Adviser Cancer Care
Macmillan Cancer Support

Lorna McInroy

Director, Clinical Biomarkers
Moderna

Kiri Granger

Co-Founder & Chief Scientific Officer
Monument Therapeutics

Radha Krishnan

Executive Director, Head of Clinical Pathology
MSD

Hilke Zander

Clinical Assessor
Paul-Ehrlich-Institut, National Competent Authority for Medicinal Products & CDx Devices

Jörg Engelbergs

Scientific-Regulatory Assessor Targeted & Personalized Biomedicines
Paul-Ehrlich-Institut, National Competent Authority for Medicinal Products & CDx Devices

Jason Simon

Precision Medicine Professionals
Regeneron

Jai Pandey

Head, Global Device Regulatory for IVDs & Digital Health
Sanofi

Philip Beer

Chief Scientific Officer
Step Pharma

Franz Stark

Senior Manager, Quality Assurance IVDs
Takeda

Alastair Greystoke

Honorary Medical Oncologist & Professor of Oncology
The Newcastle upon Tyne Hospitals NHS Foundation Trust & Newcastle University

Rolf Thermann

Section Manager IVD & Companion Diagnostics Lead
TUV Rheinland

Paola Nasuti

Real-World Evidence Senior Strategy Lead
UCB

Neil Hawkins

Professor, Health Technology Assessment
University of Glasgow

Jose Munoz-Olaya

Chief Scientific Officer
Valink Therapeutics

Category 4

Charlotte Herd

Associate Director, International Marketing, Precision Medicine, Oncology
Abbvie

David Krige

Chief Development Officer
Accession Therapeutics

Monika Lamba

Global Translational Pathology Leader
ADC Therapeutics

Stewart McWilliams

Global Vice President, Quality & Regulatory Affairs
Almac Diagnostic Services

EK Kim

Head of Global Commercial Biomarkers & Diagnostics
Amgen

Aino Telaranta-Keerie

Senior Director, Global Precision Medicine Lead
Astellas Pharma

Sophie Wildsmith

Executive Director, Head of PMB Immuno-Oncology (IO) Franchise
AstraZeneca

Ruairidh Edwards

Translational Scientist
Avacta Therapeutics

Anna Ettorre

Director Translational Science, Bioassays & Biomarkers
AviadoBio

Kate Simon

Senior Director, Global Regulatory Strategy IVD
Bayer

Kathrin Schlüter

Medical Affairs Manager (Europe, Middle East, & Africa)
BD Medical Essentials, Specimen Management

Dennis Merkle

CDx Commercialization Lead
Boehringer Ingelheim

Simon Vincent

Chief Scientific Officer
Breast Cancer Now

Jonathan Beer

Senior Director, Precision Medicine
Bristol Myers Squibb

Angela Douglas

President
British In Vitro Diagnostics Association

Dominic Smeithurst

Chief Medical Officer
Corbus Pharmaceuticals

Nicole Chaves Petronzi

Senior Director, Global Regulatory Affairs Diagnostics
Eli Lilly & Co.

Matthew Brown

Chief Scientific Officer
Genomics England

Eleanor Barr

AI Product Manager
GlaxoSmithKline

Catherine Mela

Executive Director, Head Biomarker Operations
GlaxoSmithKline

Sarah Stanhope

Director Translational Medicine
Immunocore

Leonie De Visser

EMEA Disease Team Leader, Bladder Cancer
Johnson & Johnson, Innovative Medicine

Dany Bell

Strategic Adviser Cancer Care
Macmillan Cancer Support

Lorna McInroy

Director, Clinical Biomarkers
Moderna

Kiri Granger

Co-Founder & Chief Scientific Officer
Monument Therapeutics

Radha Krishnan

Executive Director, Head of Clinical Pathology
MSD

Hilke Zander

Clinical Assessor
Paul-Ehrlich-Institut, National Competent Authority for Medicinal Products & CDx Devices

Jörg Engelbergs

Scientific-Regulatory Assessor Targeted & Personalized Biomedicines
Paul-Ehrlich-Institut, National Competent Authority for Medicinal Products & CDx Devices

Jason Simon

Precision Medicine Professionals
Regeneron

Jai Pandey

Head, Global Device Regulatory for IVDs & Digital Health
Sanofi

Philip Beer

Chief Scientific Officer
Step Pharma

Franz Stark

Senior Manager, Quality Assurance IVDs
Takeda

Alastair Greystoke

Honorary Medical Oncologist & Professor of Oncology
The Newcastle upon Tyne Hospitals NHS Foundation Trust & Newcastle University

Rolf Thermann

Section Manager IVD & Companion Diagnostics Lead
TUV Rheinland

Paola Nasuti

Real-World Evidence Senior Strategy Lead
UCB

Neil Hawkins

Professor, Health Technology Assessment
University of Glasgow

Jose Munoz-Olaya

Chief Scientific Officer
Valink Therapeutics
16th World Clinical Biomarkers & Companion Diagnostics Summit Europe Conference Image
Explore the Agenda

Gain first-hand insights into the latest translational, clinical and commercial strides shaping biomarker-led trials and CDx approvals. From IVDR, to the COMBINE pilot, explore Europe’s most innovative precision medicine advances through a packed agenda of expert-led sessions and exclusive Rx-Dx partnership discussions

View Presentations & Speakers
16th World Clinical Biomarkers & Companion Diagnostics Summit Europe Conference Image
Partner With Us

Position your brand alongside leading global and European-local IVD innovators, clinical and biosample management leaders and laboratory service to stay of the pinnacle of bringing precision therapeutics from bench-to-bedside

Explore Sponsorship Options
16th World Clinical Biomarkers & Companion Diagnostics Summit Europe Conference Image
Join Biopharma Experts

Join Europe’s most comprehensive and trusted senior precision medicine community for dynamic and high-impact conversations across diverse precision medicine therapy areas, modalities, biosample types and testing platforms

Register Now